Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Sullivan

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
Clinical Orthopaedics and Related Research|January 5, 2002
Prevention of dislocation after hip arthroplasty: lessons from long-term followupJ J Callaghan, B E Heithoff, D D Goetz, et al.
The American Journal of Physiology|June 1, 1996
Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human isletsJ A Corbett, G Kwon, M H Marino, et al.
The Journal of Biological Chemistry|July 18, 1997
Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosisP M Sullivan, H Mezdour, Y Aratani, et al.
Neuroscience|December 26, 2006
An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interactionH Wang, L Durham, H Dawson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
Characterization and expression of the complementary DNA encoding rat histidine decarboxylaseD R Joseph, P M Sullivan, Y M Wang, et al.
The American Journal of Physiology|January 22, 1998
TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanismsN K Worrall, K Chang, W S LeJeune, et al.
The Journal of Clinical Investigation|June 8, 1999
Apo E structure determines VLDL clearance and atherosclerosis risk in miceC Knouff, M E Hinsdale, H Mezdour, et al.
Clinical and Experimental Immunology|October 2, 2020
Inactivation of TMEM106A promotes lipopolysaccharide-induced inflammation via the MAPK and NF-κB signaling pathways in macrophagesX Zhang, T Feng, X Zhou, et al.
The Journal of Bone and Joint Surgery. American Volume|February 3, 2005
Total hip arthroplasty with cement and without acetabular bone graft for severe hip dysplasia. A concise follow-up, at a minimum of twenty years, of a previous reportA S Klapach, J J Callaghan, K A Miller, et al.
Neurobiology of Aging|July 7, 2009
Reduced levels of human apoE4 protein in an animal model of cognitive impairmentP M Sullivan, B Han, F Liu, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
Clinical Orthopaedics and Related Research|January 5, 2002
Prevention of dislocation after hip arthroplasty: lessons from long-term followupJ J Callaghan, B E Heithoff, D D Goetz, et al.
The American Journal of Physiology|June 1, 1996
Tyrosine kinase inhibitors prevent cytokine-induced expression of iNOS and COX-2 by human isletsJ A Corbett, G Kwon, M H Marino, et al.
The Journal of Biological Chemistry|July 18, 1997
Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosisP M Sullivan, H Mezdour, Y Aratani, et al.
Neuroscience|December 26, 2006
An apolipoprotein E-based therapeutic improves outcome and reduces Alzheimer's disease pathology following closed head injury: evidence of pharmacogenomic interactionH Wang, L Durham, H Dawson, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1990
Characterization and expression of the complementary DNA encoding rat histidine decarboxylaseD R Joseph, P M Sullivan, Y M Wang, et al.
The American Journal of Physiology|January 22, 1998
TNF-alpha causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanismsN K Worrall, K Chang, W S LeJeune, et al.
The Journal of Clinical Investigation|June 8, 1999
Apo E structure determines VLDL clearance and atherosclerosis risk in miceC Knouff, M E Hinsdale, H Mezdour, et al.
Clinical and Experimental Immunology|October 2, 2020
Inactivation of TMEM106A promotes lipopolysaccharide-induced inflammation via the MAPK and NF-κB signaling pathways in macrophagesX Zhang, T Feng, X Zhou, et al.
The Journal of Bone and Joint Surgery. American Volume|February 3, 2005
Total hip arthroplasty with cement and without acetabular bone graft for severe hip dysplasia. A concise follow-up, at a minimum of twenty years, of a previous reportA S Klapach, J J Callaghan, K A Miller, et al.
Neurobiology of Aging|July 7, 2009
Reduced levels of human apoE4 protein in an animal model of cognitive impairmentP M Sullivan, B Han, F Liu, et al.
Pageof 8